elranatamab,daratumumab
pfizer,janssen
['mmsm', 'multiple myeloma', 'elranatamab']
elranatamab, a bcma targeted t-cell engaging bispecific antibody, induces durable clinical and molecular responses for patients with relapsed or refractory multiple myeloma #ash22 #imfash22 #mmsm 
Hematology is in my ??. Posts are mine. Mayo Clinic Associate, Asst Prof, BMT RNCC, RN Navigator, emeritus. IMF NLB. MM KOL. Patient educator & advocate.